Administration of the human DKK4 recombinant protein into the xenograft sites restored the effects of reduced DKK4 expression by knocking down tumour growth of cancer stem cells from the patient sample (1597) in mice (Fig. 2A‒C). Here, DKK4 is linked to neoplasm.